This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Corneal Transplantation

Council on Scientific Affairs; George M. Bohigian, MD; E. Harvey Estes, Jr, MD; Ira R. Friedlander, MD; William R. Kennedy, MD; John H. Moxley III, MD; Patricia J. Numann, MD; Paul S. Salva, PhD; William C. Scott, MD; Joseph H. Skom, MD; Richard M. Steinhilber, MD; Jack P. Strong, MD; Henry N. Wagner, Jr, MD; Panel on Organ Transplantation; William E. Braun, MD; Sharad Deodhar, MD, PhD; Charles E. Millard, MD; Vaughn Payne, PharmD, MD; George A. Richard, MD; Norman E. Shumway, MD, PhD; Thomas E. Starzl, MD, PhD; Jack P. Strong, MD; Troy L. Thompson II, MD

JAMA. 1988;259(5):719-722.

Abstract
Corneal transplantation is the most common form of organ transplantation practiced in the United States. Two procedures for transplantation are utilized. Penetrating keratoplasty is used in about 90% of the cases, with lamellar keratoplasty being utilized in the remaining situations. Demand for corneal transplantation exceeds the available supply of corneas. Advances in procurement and preservation must continue to meet this demand. Finally, these procedures are not without complications, and these are discussed to provide a clear risk-benefit analysis.

(JAMA 1988;259:719-722)

Author Affiliations
St Louis, Chairman; Durham, NC; Chicago, Resident Representative; Minneapolis; Beverly Hills, Calif; Syracuse, NY; Lubbock, Tex, Medical Student Representative; Tucson, Vice-Chairman; Chicago; Cleveland; New Orleans; Baltimore, Md.; Cleveland; Cleveland; Warren, RI; Louisville, principle panel author; Gainesville, Fla; Stanford, Calif; Pittsburgh; New Orleans, Council on Scientific Affairs liaison; Denver

From the Council on Scientific Affairs, American Medical Association, Chicago.

Footnotes
This report was presented to the AMA House of Delegates in June 1987 as an informational report.

This report is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all of the facts and circumstances involved in an individual case and are subject to change as scientific knowledge and technology advance and patterns of practice evolve. This report reflects the views of scientific literature as of December 1986.

Reprint requests to Council on Scientific Affairs, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (William R. Hendee, PhD).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Deletion of the Chemokine Receptor CCR1 Prolongs Corneal Allograft Survival
Hamrah et al.
IOVS 2007;48:1228-1236.
ABSTRACT | FULL TEXT  

Corneal Transduction to Inhibit Angiogenesis and Graft Failure
Murthy et al.
IOVS 2003;44:1837-1842.
ABSTRACT | FULL TEXT  

Cell subpopulations in failed human corneal grafts
Kuffova et al.
Br J Ophthalmol 1999;83:1364-1369.
ABSTRACT | FULL TEXT  

Five-Year Corneal Graft Survival: A Large, Single-Center Patient Cohort
Price et al.
Arch Ophthalmol 1993;111:799-805.
ABSTRACT  

The Collaborative Corneal Transplantation Studies (CCTS) Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation
The Collaborative Corneal Transplantation Studies
Arch Ophthalmol 1992;110:1392-1403.
ABSTRACT  

Cornea Donation Laws in the United States
Lee et al.
Arch Ophthalmol 1989;107:1585-1589.
ABSTRACT  

The Politics of Organ Transplantation: A Parable of Our Time
Rettig
Journal of Health Politics, Policy and Law 1989;14:191-227.
ABSTRACT